Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher Net Sales are expected to increase by 11.9 percent Y-o-Y (down 3.5 percent Q-o-Q) to Rs 347.2 crore, according to Prabhudas Lilladher.